Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database

F Darendeliler, G Karagiannis, P Wilton - Hormone Research, 2007 - karger.com
… than in the other diagnostic groups (p < 0.05 for all). IIH … p < 0.0001), cranial tumour (p
= 0.0014) and craniopharyngioma (p = 0.0003) groups and in ISS versus cranial tumours (p

Models of consumer satisfaction formation: An extension

DK Tse, PC Wilton - Journal of marketing research, 1988 - journals.sagepub.com
… In addition, subjects in the good performance condition perceived the product to perform
better (p < .001) and were more satisfied (p < .001) than those in the poor performance condition…

Bacterial septic arthritis of the adult native knee joint: a review

JG Elsissy, JN Liu, PJ Wilton, I Nwachuku… - JBJS …, 2020 - journals.lww.com
… vulgaris, P. rettgeri, Morganella morganii Cefotaxime 2 g every 6 hours, imipenem 500
mg every 6 hours, or levofloxacin 500 mg daily … Kaandorp CJ, Van Schaardenburg D …

Achieving the unimaginable: health equity in haemophilia

MW Skinner, D Nugent, P Wilton, B O'Mahony… - …, 2020 - Wiley Online Library
… Pam Wilton has received consulting fees and travel costs to attend advisory board meetings.
Brian O’Mahony has no conflicts of interest to declare. Gerry Dolan has received consulting …

Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment

WS Cutfield, P Wilton, H Bennmarker… - The Lancet, 2000 - thelancet.com
Background Growth hormone (GH) contributes to insulin resistance, but whether children
treated with GH are at increased risk of diabetes has not been established. We undertook a …

Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study

EJ Birks, RS George, M Hedger, T Bahrami, P Wilton… - Circulation, 2011 - Am Heart Assoc
… , P=0.3 versus before explantation), the FS was 29.3±4.7% (P=0.3 versus before explantation),
LVEDD was 50.33±6.1 mm (P=0.3 versus before explantation), LVESD was 35.2±4 mm (…

Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with …

…, A Lindberg, P Chatelain, P Wilton… - The Journal of …, 1999 - academic.oup.com
… The weekly dose of GH per kg BW did not differ significantly over the years of observation
(P > 0.1). The … All single predictors were found to be significant at a level of P < 0.001. …

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

…, JP Monson, JP Tauber, P Wilton… - Clinical …, 1999 - Wiley Online Library
OBJECTIVE Long‐term experience of growth hormone (GH) replacement therapy in a large
population of hypopituitary adults with GH deficiency (GHD) is limited, and safety …

Consumer satisfaction as a process

DK Tse, FM Nicosia, PC Wilton - Psychology & Marketing, 1990 - Wiley Online Library
Consumer satisfaction has been defined as an objective or subjective state variable. This
paper presents an emerging view where satisfaction is construed as a subjective process of …

The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density

…, JP Monson, B Westberg, P Wilton - Journal of Bone and …, 2001 - academic.oup.com
To assess the influence of factors affecting fracture risk and bone density in adult
hypopituitary patients with growth hormone deficiency (GHD), data from a large‐scale …